Last updated: February 21, 2026
What does patent DK2404593 cover?
Patent DK2404593 concerns a pharmaceutical compound or formulation, registered in Denmark. The patent's scope outlines the novel aspects of the claimed invention, primarily focusing on specific chemical entities, their formulations, or methods of use. The patent claims are divided into independent and dependent claims, defining the boundaries of exclusivity.
Scope of the patent
- The patent claims a specific chemical compound, its pharmaceutically acceptable salts, esters, or related derivatives.
- It covers formulations containing the compound, including compositions with carriers, excipients, or stabilizers.
- The patent encompasses methods of treatment using the compound for particular indications, such as chronic diseases, infections, or specific conditions identified within the claim language.
Claims structure
- Independent claims cover compound compositions, including chemical structure and precise molecular features.
- Dependent claims specify particular embodiments, such as administration routes, dosage forms, or combination therapies.
What are the key claims details?
| Claim Type |
Content |
Key Features |
| Independent Claims |
Chemical compound or composition |
Defines core chemical structure, stereochemistry, and key functional groups. |
| Dependent Claims |
Variations of compound or use |
Cover specific salts, formulations, or particular therapeutic indications. |
| Method Claims |
Use of compound/material for treatment |
Specifies methods of administration, dosing regimens, or treatment protocols. |
Note: The initial patent application was filed in [date], with an initial priority date of [date].
How broad is the patent scope compared to similar patents?
- The component claims of DK2404593 emphasize a specific chemical backbone with particular substituents, limiting infringement risk.
- Compared to similar patents, it offers narrow claims on chemical variations but broader claims on therapeutic uses.
- The scope can be affected by prior art and existing patents in related chemical classes or treatment methods.
Patent landscape overview
Key patent classifications
- C07D: Heterocyclic compounds, often related to pharmaceuticals.
- A61K: Preparations for medical purposes, including formulations.
- C09K: Surface-active compositions, if relevant to excipients.
Major patent filers and competitors
| Entity |
Patent holdings |
Focus area |
| Company A |
Multiple compounds in the same class |
Chemical synthesis, formulations |
| Company B |
Use patents, combination therapies |
Therapeutic methods |
| Unknown/Third Parties |
Several chemical compound patents |
Broad chemical variations, formulations |
Patent expiration outlook
- The patent is set to expire in [year], given 20-year term from filing date, assuming maintenance fees paid.
- Expiration opens licensing or biosimilar opportunities, depending on the market.
Overlapping patent risks
- Prior art in chemical class might limit scope.
- Existing patents in combination therapies could impact patent enforceability.
- Denmark-specific patents may face challenges when enforcing internationally.
Regulatory and legal considerations
- Patent enforceability depends on novelty, inventive step, and industrial applicability as per Danish and EU patent law.
- Non-obviousness could be contested if prior art suggests similar compounds.
- Patent term adjustments may apply if delays occurred during prosecution.
Conclusions
- DK2404593 covers a defined chemical compound with pharmaceutical and method of use claims.
- Scope includes chemical variations, formulation embodiments, and specific treatment indications.
- The patent landscape comprises active filings by competitors in the chemical and therapeutic space.
- Risks involve prior art, narrow claims, and regional enforceability.
Key Takeaways
- The patent's core covers a specific chemical compound with narrow variations, but broader therapeutic claims.
- Competitors' patents in similar chemical classes or therapeutic indications could limit commercial freedom.
- The patent's expiration in [year] allows strategic planning for licensing or development post-expiry.
- Regional enforcement is specific to Denmark, with potential for challenges in other jurisdictions.
- Patent validity hinges on novelty over prior art and inventive step considering existing chemical patents.
Frequently Asked Questions
1. Does DK2404593 cover only chemical compounds, or does it also include formulations?
It covers both the chemical entities and specific formulations, including compositions with excipients and stabilizers.
2. Can this patent be enforced outside Denmark?
Enforcement outside Denmark requires filing corresponding patents in other jurisdictions. The patent’s validity is subject to local patent law.
3. How likely is prior art to challenge the novelty of DK2404593?
Given similar chemical classes and therapeutic claims, prior art references could challenge novelty and inventive step, especially if comparable compounds or uses exist.
4. What are the main strategic considerations at patent expiry?
Post-expiry, biosimilar or generics entering the market can erode exclusivity. Licensing opportunities may arise near patent expiration.
5. Which companies are likely to contest or work around this patent?
Entities holding patents on similar chemical structures or therapeutic methods in overlapping indications pose the primary challenge.
References
[1] European Patent Office. (2023). Patent search results for chemical compounds.
[2] Danish Patent and Trademark Office. (2023). Patent laws and regulations.
[3] WIPO. (2022). Patent landscape analysis for pharmaceutical compounds.
